Novacyt (ALNOV.FP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Euronext FR]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Euronext FR]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 20,029 | 19,630 | 11,579 | 21,040 | 95,780 |
| Cost of Goods | 7,415 | -12,444 | 7,849 | 15,294 | 66,102 |
| Gross Profit | 12,614 | 32,074 | 3,730 | 5,746 | 29,678 |
| Operating Expenses | 24,992 | 48,734 | 21,892 | 21,421 | 30,308 |
| Operating Income | -12,378 | -16,660 | -18,162 | -15,675 | -630 |
| Interest Expense | 600 | 5,121 | 682 | 76 | 178 |
| Other Income | -14,368 | -17,649 | -9,724 | -4,302 | -9,021 |
| Pre-tax Income | -27,346 | -39,430 | -28,568 | -20,053 | -9,829 |
| Income Tax | -3,894 | -732 | -768 | 2,148 | -101 |
| Net Income Continuous | -23,452 | -38,698 | -27,800 | -22,201 | -9,728 |
| Net Income Discontinuous | 569 | -3,060 | -492 | -3,529 | N/A |
| Net Income | $-22,883 | $-41,758 | $-28,292 | $-25,730 | $-9,728 |
| EPS Basic Total Ops | N/A | -0.59 | -0.40 | -0.36 | -0.14 |
| EPS Basic Continuous Ops | N/A | -0.55 | -0.39 | -0.31 | -0.14 |
| EPS Basic Discontinuous Ops | N/A | -0.04 | -0.01 | -0.05 | N/A |
| EPS Diluted Total Ops | N/A | -0.59 | -0.40 | -0.36 | -0.14 |
| EPS Diluted Continuous Ops | N/A | -0.55 | -0.39 | -0.31 | -0.14 |
| EPS Diluted Discontinuous Ops | N/A | -0.04 | -0.01 | -0.05 | N/A |
| EBITDA(a) | $-8,182 | $-34,309 | $-18,243 | $-12,059 | $-1,769 |